Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola
Clinical trial NCT04186000 · COMPLETED
Trial details
- NCT number
- NCT04186000
- Sponsor
- Universiteit Antwerpen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2020-04-25
- Enrollment
- 699
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.